Section 23: Electronic Drugs Register

23. Electronic Drugs Register (1) For the purpose of this section – (a) a pharmacist or a designated person who purchases or otherwise obtains dangerous drugs, or who sells or supplies dangerous drugs; Acts 2023 201 (b) a medical practitioner, a dental surgeon, a veterinary surgeon or a designated person who purchases, obtains or supplies dangerous drugs; (c) a manufacturer, an importer, an exporter, a wholesaler or a retailer of dangerous drugs, shall keep a Drugs Register into which entries, in respect of every transaction of dangerous drugs effected by him or any person under his control, shall be made electronically in such manner as the Permanent Secretary may determine. (2) Where a pharmacist or any person under his control sells or supplies dangerous drugs, he shall, not later than 24 hours after the sale or supply, make entries in the Poisons Register kept by him under the Pharmacy Act and make entries into the Drugs Register, of the particulars of every dangerous drug sold or supplied by him and a reference for easy identification of each corresponding entry in the Poisons Register. (3) Where any entry is required to be made into the Drugs Register pursuant to subsection (1) or (2), it shall – (a) specify the date of the transaction; (b) specify the name and the quantity of the dangerous drugs transacted; (c) be expressed – (i) in the case of a solid, in grammes; (ii) in the case of a powder, solution or ointment, in terms of the total quantity of the dangerous drugs transacted and the percentage of the dangerous drug contained in it; (iii) in the case of tablets and other articles, in terms of the total quantity of the dangerous drugs contained in the tablet or article; and 202 Acts 2023 (iv) in the case of a liquid, in millilitres; (d) where a transaction is made by a pharmacist in respect of a dangerous drug listed in the Second, Third and Fifth Schedules, specify the name of the medical practitioner, dental surgeon or veterinary surgeon who issued the prescription and the name of the purchaser; and (e) where a transaction is made by a manufacturer, an importer, an exporter, a wholesaler or a retailer in respect of a substance listed in the Fourth Schedule, specify the name, address and profession of both the purchaser and vendor; (f) specify such other information as the Permanent Secretary may determine. (4) No entry made into the Drugs Register under subsection (1) or (2) shall – (a) be altered otherwise than by a footnote duly dated by him, giving the particulars of the alteration; and (b) be cancelled or obliterated. (5) A separate Drugs Register shall be kept in respect of each place of business where a transaction of dangerous drugs is effected and shall be made available for inspection at all times. (6) Every pharmacist shall – (a) on or before 15 January in every year, furnish the Permanent Secretary with a statement, electronically in such manner as the Permanent Secretary may determine, containing all information Acts 2023 203 in respect of any dangerous drugs delivered to him or obtained from him and the stock of dangerous drugs during the preceding year; and (b) on request, give to the Permanent Secretary such particulars of his stock of dangerous drugs or of any transaction involving a dangerous drug as the Permanent Secretary may require. (7) In this section – “designated person” means such person as the Permanent Secretary may designate. (b) by repealing section 24 and replacing it by the following section –